Skip to content

MAREPHAR: what changed

BE 0479.955.109NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€17,387
2024 · €14,741+€2,646
Equity
€522,667
2024 · €506,664+€16,003
Cash
€96,571
2024 · €162,421-€65,850
Balance sheet total
€1.5m
2024 · €1.6m-€66,979

Largest movements

2024 to 2025
Assets
  • Cash -€65,850

    down €65,850 (-40.5%), from €162,421 to €96,571

    mainly Debts after one year (-€104,419) and Investment in fixed assets (net) (-€39,341)

  • Tangible fixed assets -€36,864

    down €36,864 (-3.1%), from €1.2m to €1.1m

    of which Plant, machinery and equipment: -€40,841

  • Receivables within one year +€32,761

    up €32,761 (+38.3%), from €85,565 to €118,327

    of which Trade receivables: +€33,019

Equity and liabilities
  • Debts after one year -€104,419

    down €104,419 (-13.4%), from €777,666 to €673,246

    of which Financial debts: -€104,419

  • Trade debts +€52,415

    up €52,415 (+65.8%), from €79,670 to €132,085

  • Other debts -€27,565

    down €27,565 (-44.4%), from €62,089 to €34,524

  • Reserves +€16,003

    up €16,003 (+3.3%), from €488,064 to €504,067

    of which Distributable reserves: +€16,003

Income statement
  • Gross operating margin -€13,797

    down €13,797 (-6.4%), from €217,015 to €203,218

  • Depreciation -€9,284

    down €9,284 (-10.9%), from €85,489 to €76,205

  • Staff costs -€4,244

    down €4,244 (-4.3%), from €98,600 to €94,356

  • Financial charges -€3,926

    down €3,926 (-23.6%), from €16,664 to €12,738

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €14,741
Gross operating margin -€13,797
Staff costs +€4,244
Depreciation +€9,284
Other operating charges -€596
Financial income -€412
Financial charges +€3,926
Taxes -€4
Result 2025 €17,387
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€78,100
Investment -€39,341
Financing -€104,609
Cash 2024 €162,421
Net result for the year +€17,387
Depreciation +€76,205
Stocks and contracts -€2,643
Receivables within one year -€32,761
Deferred charges and accrued income -€331
Trade debts +€52,415
Tax, wage and social debts -€2,898
Other debts -€27,565
Accrued charges and deferred income -€1,709
Investment in fixed assets (net) -€39,341
Debts after one year -€104,419
Current portion of long-term debt +€1,194
Contributions, distributions and other -€1,383
Cash 2025 €96,571
brings cash intakes cash out
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,558,909 €1,491,930 -€66,979 -4.3%
Fixed assets 21/28 €1,188,966 €1,152,102 -€36,864 -3.1%
Tangible fixed assets 22/27 €1,186,466 €1,149,602 -€36,864 -3.1%
Land and buildings 22 €892,433 €896,409 +€3,977 +0.4%
Plant, machinery and equipment 23 €294,033 €253,192 -€40,841 -13.9%
Financial fixed assets 28 €2,500 €2,500 = 0.0%
Current assets 29/58 €369,943 €339,828 -€30,115 -8.1%
Stocks and contracts in progress 3 €116,405 €119,048 +€2,643 +2.3%
Stocks 30/36 €116,405 €119,048 +€2,643 +2.3%
Amounts receivable within one year 40/41 €85,565 €118,327 +€32,761 +38.3%
Trade receivables 40 €82,096 €115,114 +€33,019 +40.2%
Other amounts receivable 41 €3,470 €3,212 -€257 -7.4%
Cash at bank and in hand 54/58 €162,421 €96,571 -€65,850 -40.5%
Deferred charges and accrued income 490/1 €5,552 €5,883 +€331 +6.0%
Total equity and liabilities 10/49 €1,558,909 €1,491,930 -€66,979 -4.3%
Equity 10/15 €506,664 €522,667 +€16,003 +3.2%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €488,064 €504,067 +€16,003 +3.3%
Tax-exempt reserves 132 €13,174 €13,174 = 0.0%
Distributable reserves 133 €474,890 €490,893 +€16,003 +3.4%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €1,052,245 €969,263 -€82,982 -7.9%
Amounts payable after more than one year 17 €777,666 €673,246 -€104,419 -13.4%
Financial debts 170/4 €777,666 €673,246 -€104,419 -13.4%
Trade debts 175 €0 - =
Amounts payable within one year 42/48 €269,244 €292,391 +€23,147 +8.6%
Current portion of amounts payable after more than one year 42 €103,225 €104,419 +€1,194 +1.2%
Trade debts 44 €79,670 €132,085 +€52,415 +65.8%
Suppliers 440/4 €79,670 €132,085 +€52,415 +65.8%
Taxes, remuneration and social security 45 €24,260 €21,362 -€2,898 -11.9%
Taxes 450/3 €5,813 €6,351 +€538 +9.3%
Remuneration and social security 454/9 €18,448 €15,012 -€3,436 -18.6%
Other amounts payable 47/48 €62,089 €34,524 -€27,565 -44.4%
Accrued charges and deferred income 492/3 €5,335 €3,626 -€1,709 -32.0%
Remuneration, social security and pensions 62 €98,600 €94,356 -€4,244 -4.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €85,489 €76,205 -€9,284 -10.9%
Other operating charges 640/8 €3,378 €3,974 +€596 +17.6%
Gross operating margin 9900 €217,015 €203,218 -€13,797 -6.4%
Operating profit (loss) 9901 €29,548 €28,683 -€865 -2.9%
Financial income 75/76B €1,984 €1,572 -€412 -20.8%
Recurring financial income 75 €1,984 €1,572 -€412 -20.8%
Financial charges 65/66B €16,664 €12,738 -€3,926 -23.6%
Recurring financial charges 65 €16,664 €12,738 -€3,926 -23.6%
Profit (loss) for the period before taxes 9903 €14,867 €17,517 +€2,650 +17.8%
Income taxes 67/77 €127 €131 +€4 +3.2%
Profit (loss) for the period 9904 €14,741 €17,387 +€2,646 +18.0%
Profit (loss) for the period to be appropriated 9905 €14,741 €17,387 +€2,646 +18.0%

Value

latest balance sheet 30-09-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€334,630 to €363,948

Midpoint €346,846 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €522,667
Capitalised earnings €146,593 to €205,230
Indication €334,630 to €363,948

Adjusted equity

balance sheet 30-09-2025
Equity (10/15)
€522,667
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€522,667

Capitalised earnings

net result for the year (9904)
2025
€17,387
2024
€14,741
2023
€29,443
2022
€69,982
2021
-€90,038
excluding non-recurring income and charges
€30,271
Average result
€20,523
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€146,593 / €171,025 / €205,230

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 September 2024 and 30 September 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 10 November 2026 via checked.be.